Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 22 | 2021 | 685 | 1.860 |
Why?
|
| RNA Interference | 13 | 2021 | 618 | 1.400 |
Why?
|
| Caenorhabditis elegans Proteins | 16 | 2021 | 430 | 1.170 |
Why?
|
| RNA, Small Interfering | 14 | 2021 | 927 | 0.940 |
Why?
|
| RNA, Helminth | 7 | 2013 | 47 | 0.720 |
Why?
|
| Parasitology | 1 | 2015 | 4 | 0.450 |
Why?
|
| Molecular Biology | 1 | 2015 | 67 | 0.420 |
Why?
|
| Sumoylation | 2 | 2021 | 17 | 0.350 |
Why?
|
| Heterochromatin | 2 | 2021 | 89 | 0.340 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2011 | 29 | 0.340 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 443 | 0.320 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 386 | 0.320 |
Why?
|
| MicroRNAs | 3 | 2014 | 697 | 0.310 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 103 | 0.300 |
Why?
|
| Argonaute Proteins | 7 | 2021 | 145 | 0.300 |
Why?
|
| Schizosaccharomyces | 1 | 2010 | 104 | 0.290 |
Why?
|
| Germ Cells | 6 | 2013 | 110 | 0.280 |
Why?
|
| Animals | 25 | 2021 | 20962 | 0.250 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2020 | 103 | 0.250 |
Why?
|
| Ribonuclease III | 5 | 2020 | 87 | 0.250 |
Why?
|
| Endoribonucleases | 3 | 2015 | 56 | 0.250 |
Why?
|
| Gene Silencing | 5 | 2021 | 405 | 0.220 |
Why?
|
| Transcription, Genetic | 3 | 2021 | 883 | 0.210 |
Why?
|
| Genome, Helminth | 2 | 2014 | 11 | 0.200 |
Why?
|
| Histone Deacetylase 1 | 1 | 2021 | 19 | 0.170 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 47 | 0.170 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 391 | 0.160 |
Why?
|
| Molecular Sequence Data | 7 | 2015 | 1997 | 0.140 |
Why?
|
| Spermatogenesis | 2 | 2020 | 72 | 0.140 |
Why?
|
| RNA Caps | 2 | 2020 | 17 | 0.140 |
Why?
|
| RNA | 1 | 2020 | 429 | 0.130 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2016 | 34 | 0.130 |
Why?
|
| RNA, Double-Stranded | 3 | 2015 | 111 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 534 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 785 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 110 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2014 | 3070 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 205 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2016 | 217 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2016 | 220 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 181 | 0.110 |
Why?
|
| Vesiculovirus | 1 | 2014 | 8 | 0.110 |
Why?
|
| Lepidoptera | 1 | 2014 | 9 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 309 | 0.110 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 128 | 0.110 |
Why?
|
| Deoxyribonucleases | 1 | 2014 | 32 | 0.100 |
Why?
|
| Vaccinia virus | 1 | 2014 | 73 | 0.100 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2014 | 32 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 306 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2015 | 140 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2014 | 106 | 0.100 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2014 | 101 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 207 | 0.100 |
Why?
|
| Transcription Initiation Site | 1 | 2012 | 51 | 0.100 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2013 | 49 | 0.100 |
Why?
|
| beta Catenin | 1 | 2013 | 99 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2013 | 100 | 0.090 |
Why?
|
| Viral Proteins | 1 | 2014 | 266 | 0.090 |
Why?
|
| Epigenomics | 1 | 2012 | 62 | 0.090 |
Why?
|
| Cytoplasmic Granules | 2 | 2015 | 53 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 74 | 0.080 |
Why?
|
| Gene Library | 1 | 2011 | 102 | 0.080 |
Why?
|
| Mutation | 5 | 2014 | 2629 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 644 | 0.080 |
Why?
|
| Melanoma | 1 | 2014 | 331 | 0.080 |
Why?
|
| Antibodies | 1 | 2011 | 186 | 0.080 |
Why?
|
| Base Sequence | 3 | 2014 | 1332 | 0.080 |
Why?
|
| Epitopes | 1 | 2011 | 292 | 0.080 |
Why?
|
| Chromosome Segregation | 1 | 2009 | 40 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 783 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 410 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 1597 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2011 | 709 | 0.070 |
Why?
|
| Genome | 1 | 2009 | 276 | 0.060 |
Why?
|
| Transgenes | 2 | 2005 | 188 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2020 | 302 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1681 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 685 | 0.060 |
Why?
|
| Retinoblastoma | 1 | 2005 | 27 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2016 | 281 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 416 | 0.050 |
Why?
|
| Disorders of Sex Development | 1 | 2003 | 11 | 0.050 |
Why?
|
| Skin Absorption | 1 | 2003 | 16 | 0.050 |
Why?
|
| Breeding | 1 | 2003 | 26 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 53 | 0.050 |
Why?
|
| Microinjections | 1 | 2003 | 69 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2003 | 110 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2016 | 614 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 361 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 429 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2003 | 374 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 272 | 0.040 |
Why?
|
| Protein Binding | 3 | 2011 | 1619 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1494 | 0.040 |
Why?
|
| Meiosis | 1 | 2021 | 67 | 0.040 |
Why?
|
| Ovum | 1 | 2021 | 63 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2015 | 302 | 0.040 |
Why?
|
| RNA-Induced Silencing Complex | 2 | 2011 | 66 | 0.040 |
Why?
|
| Models, Biological | 3 | 2013 | 1187 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1365 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2020 | 340 | 0.040 |
Why?
|
| Genes, Helminth | 2 | 2013 | 57 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 1196 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 233 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 948 | 0.030 |
Why?
|
| HMGA2 Protein | 1 | 2016 | 4 | 0.030 |
Why?
|
| HMGA Proteins | 1 | 2016 | 5 | 0.030 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Butadienes | 1 | 2016 | 12 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2016 | 17 | 0.030 |
Why?
|
| Niacinamide | 1 | 2016 | 32 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 31 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 59 | 0.030 |
Why?
|
| Mice | 3 | 2016 | 11003 | 0.030 |
Why?
|
| ras Proteins | 1 | 2016 | 77 | 0.030 |
Why?
|
| Pyridones | 1 | 2016 | 42 | 0.030 |
Why?
|
| Nitriles | 1 | 2016 | 79 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1551 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2016 | 56 | 0.030 |
Why?
|
| Alleles | 2 | 2009 | 448 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
| Exoribonucleases | 2 | 2006 | 30 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 189 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 204 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 587 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 313 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 373 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 901 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2014 | 28 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 430 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 130 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2014 | 89 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 73 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 136 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2013 | 19 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2014 | 106 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 51 | 0.030 |
Why?
|
| Cricetinae | 1 | 2014 | 368 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 239 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 671 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 64 | 0.030 |
Why?
|
| Plasmids | 1 | 2014 | 293 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2014 | 234 | 0.020 |
Why?
|
| Prophase | 1 | 2013 | 13 | 0.020 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 364 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2013 | 64 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 402 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2012 | 52 | 0.020 |
Why?
|
| Virus Replication | 1 | 2014 | 323 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2013 | 109 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2012 | 87 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 365 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 82 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 695 | 0.020 |
Why?
|
| Spindle Apparatus | 1 | 2013 | 124 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 1769 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2140 | 0.020 |
Why?
|
| Cell Division | 1 | 2013 | 454 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2013 | 261 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 179 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2055 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1001 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 704 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1176 | 0.020 |
Why?
|
| Female | 3 | 2021 | 33351 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2009 | 128 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2009 | 261 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 312 | 0.020 |
Why?
|
| Male | 2 | 2013 | 30295 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2009 | 180 | 0.020 |
Why?
|
| Phylogeny | 1 | 2009 | 385 | 0.020 |
Why?
|
| Fertility | 1 | 2008 | 83 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 909 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 674 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2008 | 102 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 3724 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2006 | 98 | 0.010 |
Why?
|
| Vulva | 1 | 2005 | 18 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2006 | 385 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2006 | 312 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 303 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2005 | 273 | 0.010 |
Why?
|
| Proteomics | 1 | 2006 | 294 | 0.010 |
Why?
|
| Humans | 3 | 2016 | 64243 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 1222 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1621 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2005 | 1540 | 0.010 |
Why?
|